INSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Inspire Medical Systems Inc (INSP) does not present a compelling buy opportunity for a beginner, long-term investor at this time. The stock is facing near-term uncertainties, including reimbursement challenges and decelerating domestic growth, as highlighted by analysts. While the company's financial performance in Q4 2025 was strong, the lack of recent positive trading signals, neutral insider and hedge fund activity, and the absence of significant news catalysts suggest a cautious approach. The technical indicators and options data do not strongly support an immediate buy decision.
The MACD histogram is positive at 0.996, indicating bullish momentum, but it is contracting, suggesting weakening strength. RSI is neutral at 60.747, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 55.169, with resistance at 58.111 and support at 52.228, indicating limited upside potential in the short term.
Strong Q4 2025 financial performance with revenue up 12.25% YoY, net income up 286.36% YoY, and EPS up 301.72% YoY. Gross margin also improved to 86.59%.
Analysts have lowered price targets across the board, citing reimbursement challenges, decelerating domestic growth, and limited visibility into near-term trends. The stock's discount relative to peers is justified by these uncertainties. No recent news or significant insider/hedge fund activity to drive momentum.
In Q4 2025, revenue increased to $269.08M (up 12.25% YoY), net income rose to $136.09M (up 286.36% YoY), EPS grew to 4.66 (up 301.72% YoY), and gross margin improved to 86.59% (up 1.88% YoY). These results reflect strong growth but are overshadowed by near-term uncertainties.
Analysts have lowered price targets significantly, with the latest ratings ranging from $56 to $70. Ratings include Hold, Sector Perform, and Outperform, but all highlight near-term uncertainties such as reimbursement friction, coding headwinds, and decelerating growth. Sentiment remains cautious despite some long-term optimism.
